Biotechnology
Company Overview of Biolex Therapeutics, Inc., LEX SystemSM and Two Biological Drug Candidates
Company Overview
AS of April 20, 2012, LEX SystemSM and Two Biological Drug Candidates of Biolex Therapeutics, Inc. were acquired by Synthon Holding B.V. LEX SystemSM and Two Biological Drug Candidates of Biolex Therapeutics, Inc. comprises LEX SystemSM, a proprietary biologics manufacturing platform and two promising biological drug candidates that produce proteins and antibodies.
,
United States
Key Executives for Biolex Therapeutics, Inc., LEX SystemSM and Two Biological Drug Candidates
Biolex Therapeutics, Inc., LEX SystemSM and Two Biological Drug Candidates does not have any Key Executives recorded.
Similar Private Companies By Industry
| Company Name | Region |
| Genomic Nanosystems, LLC | United States |
| Targeted Growth, Inc. | United States |
| HDK Enterprises, Inc. | United States |
| Interfacial Dynamics Corporation | United States |
| PlexPress, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Efland, NC | Orange County SchoolsPosted: May 22
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Biolex Therapeutics, Inc., LEX SystemSM and Two Biological Drug Candidates, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
